TABLE 1.

Correlation of RIPK4 expression with clinicopathological features in HCC.

Parameters	Number	RIPK4		χ2	P
		Low	High
Gender				0.015	0.903 a
Male	94	56	38
Female	18	11	7
Age(y)				0.595	0.44 a
<50	21	11	10
≥50	91	56	35
Alcohol abuse				0.134	0.715 a
Yes	32	20	12
No	80	47	33
Tumor size (cm)				0.178	0.673 a
≤5	62	31	19
>5	50	36	26
Tumor margin (cm)				0.303	0.582 a
≤2	97	59	38
>2	15	8	7
Pathologic differentiation				1.202	0.273 a
Middle and low	81	51	30
High	31	16	15
Microvascular invasion				4.795	0.029 a
No	71	37	34
Yes	41	30	11
Liver cirrhosis				0.131	0.717 a
No	23	13	10
Yes	89	54	35
HBV infection				1.000 c
No	8	5	3
Yes	104	62	42
Capsule invasion				1.649	0.199 a
No	37	19	18
Yes	48	39	27
Portal vein tumor thrombus				0.490	0.484 b
No	101	62	39
Yes	11	5	6
AFP level (ng/L)				0.315	0.575 a
≤400	78	48	30
>400	34	19	15
ALB level (g/L)				0.492	0.483 a
≤35	19	10	9
>35	93	57	36
ALT level (U/L)				1.871	0.171 a
≤60	87	55	32
>60	25	12	13
AST level (U/L)				2.332	0.127 a
≤42	81	52	29
>42	31	15	16
PLT level (104/μL)				0.967	0.326 a
≤10	17	12	5
>10	95	55	40
TBIL level (μmol/L)				1.099	0.295 a
≤22	90	56	34
>22	22	11	11

^aPearson’s χ² test.

^bContinuity correction by χ² test.

^cFisher’s exact test; *p < 0.05, statistically significant.

The meaning of the bold values: p < 0.05